US Patent 11911465 Vaccine compositions and methods of use
Patent 11911465 was granted and assigned to Pds Biotechnology Corporation on February, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+25 properties)
Article (+597 characters)
US Patent 11911465 Vaccine compositions and methods of use
Article
Patent abstract
The present disclosure provides vaccine compositions comprising at least one adjuvant and at least one antigen, wherein the adjuvant is a cationic lipid. The disclosure also provides methods of treating a disease in a mammal, methods of preventing a disease in a mammal, and methods of effecting antigen cross presentation to induce a humoral immune response and a cellular immune response in a mammal utilizing the vaccine compositions. Cross presentation of various antigens can be achieved by formulating the specific antigens with cationic lipids possessing adjuvant properties.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Eric Jacobson0
Frank Bedu-Addo0
Kenya Johnson0
Date of Patent
February 27, 2024
0Patent Application Number
173833780
Date Filed
July 22, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11911465 Vaccine compositions and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
